Literature DB >> 22530221

Hemostatic matrix application after open synovectomy in a hemophilic patient.

Manuel García Aríz1, Omar Pérez-Carrasquillo, Charles E Zierenberg, Jorge Cheleuitte, Jhon A Guerra, Pedro J Santiago-Borrero.   

Abstract

Recurrent, spontaneous bleeding is common in patients with hemophilia. The joints are commonly and repeatedly affected, and this can result in chronic synovitis and joint damage. Synoviorthesis or synovectomy are indicated after failure of appropriate medical management. Hemostasis in the perioperative period is paramount in these patients. We report a case study of a patient with hemophilia A inhibitors undergoing open synovectomy complicated by postoperative bleeding. In addition to an infusion of bypassing agents due to the presence of inhibitors, a topical hemostatic agent, FLOSEAL, and absorbable Gelfoam were applied. Hemostasis was achieved rapidly. The patient recovered without complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530221

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Comparison of Floseal(r) and electrocautery in hemostasis after total knee arthroplasty.

Authors:  Camilo Partezani Helito; Riccardo Gomes Gobbi; Lucas Machado Castrillon; Betina Bremer Hinkel; José Ricardo Pécora; Gilberto Luis Camanho
Journal:  Acta Ortop Bras       Date:  2013       Impact factor: 0.513

2.  Comparison of Floseal® and Tranexamic Acid for Bleeding Control after Total Knee Arthroplasty: a Prospective Randomized Study.

Authors:  Camilo Partezani Helito; Marcelo Batista Bonadio; Marcel Faraco Sobrado; Pedro Nogueira Giglio; José Ricardo Pécora; Gilberto Luis Camanho; Marco Kawamura Demange
Journal:  Clinics (Sao Paulo)       Date:  2019-11-25       Impact factor: 2.365

3.  Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.

Authors:  Melinda H MacDonald; Gary Zhang; Laura Tasse; Daidong Wang; Hector De Leon; Richard Kocharian
Journal:  J Mater Sci Mater Med       Date:  2021-09-30       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.